The Gambling Addiction Recovery, Investment, and Treatment Act establishes federal grants to help states address gambling addiction and funds research on the issue. States will receive grants based on the same allocation method used for existing substance abuse prevention and treatment programs, with unclaimed funds redistributed to applying states. The bill authorizes funding from 37.5% of annual gambling tax revenue for state programs and 12.5% for research through the National Institute on Drug Abuse, covering fiscal years 2025-2034. It requires a congressional report on program effectiveness within three years of enactment.
This bill extends the Affordable Care Act's premium tax credit through 2028 (instead of 2026) and raises the household income eligibility cap from 400% to 700% of the federal poverty level. It allows individuals to receive advance credit payments directly into their Health Savings Accounts (HSAs) or to their insurance issuer, depending on their plan type and election. The bill also establishes a minimum monthly premium responsibility amount for coverage and requires federal agencies to verify immigration status for tax credit eligibility. These changes primarily affect low-to-moderate income individuals purchasing health insurance through the ACA marketplace.
This bill clarifies that temporary medical staff (locum tenens physicians and advanced practitioners) working in rural or underserved areas are treated as independent contractors - not employees - by federal programs for key purposes. It specifically affects how these temporary workers are classified under the Fair Labor Standards Act, Civil Rights Act, Medicare, Medicaid, and other federal health programs, ensuring they aren’t deemed employees of the healthcare facility they temporarily serve. The bill requires a written agreement between the temporary staff and the facility, with an exception for cases where an explicit employer-employee contract is signed. It explicitly does not change tax treatment, state licensing rules, or eligibility for Medicare/Medicaid benefits.
HR 6148, the Patients Over Paperwork Act of 2025, repeals Section 71107 of Public Law 119-21, which had changed how states review Medicaid eligibility. It restores the previous rules for Medicaid eligibility redeterminations as if that section had never been enacted. This directly affects Medicaid beneficiaries and state Medicaid programs by reverting to the pre-2024 process for verifying ongoing eligibility.
This bill creates a federal grant program to support K-12 schools in preparing for students with epilepsy or seizure disorders. It provides $34.5 million (2026-2030) for states to fund local schools to train staff on seizure awareness, develop personalized emergency care plans, and ensure proper medical accommodations. Schools must train all staff every two years, provide bus drivers with student-specific care information, and create detailed health plans covering symptoms, activity accommodations, and communication protocols. The program supplements existing funding and protects school staff from liability for good-faith actions related to implementing these requirements.
S.1329, the PEER Support Act, establishes formal standards for peer support specialists in mental health and substance use recovery. It defines the profession (requiring lived experience and certification), mandates the federal government to create a new occupational category for these specialists by 2026, and creates an Office of Recovery within SAMHSA to support workforce development and best practices. The bill also requires a federal report analyzing state criminal background check policies for peer specialists and recommending ways to reduce barriers to certification. This legislation directly affects peer support specialists, state certification agencies, and federal agencies like SAMHSA, aiming to professionalize the field and improve access to recovery support services.
This bill creates a new Medicaid health home program specifically for people with sickle cell disease (SCD), beginning January 1, 2026. It requires states to provide dental and vision services to SCD patients enrolled in these health homes, regardless of whether they offer such services generally to other Medicaid beneficiaries. States must also report on care quality, access, and costs for SCD patients using these specialized health homes, and the federal government must publish best practices for implementing the program by June 2026. The bill directly affects Medicaid patients diagnosed with SCD and state Medicaid programs managing these specialized care services.
The Veteran Families Health Services Act of 2025 expands reproductive health services for military members and veterans. It requires the Department of Defense to provide fertility preservation services, including cryopreservation of reproductive genetic material before deployment or hazardous assignments for active duty service members. The bill also mandates the Department of Veterans Affairs to provide fertility treatment, counseling, and adoption assistance to veterans and their partners without regard to sex, gender identity, or sexual orientation. The law establishes coordination between military and VA health services to ensure continuity of care during the transition from active duty to veteran status. It includes provisions allowing veterans to maintain control over stored genetic material and make decisions about its use.
S 526, the Pharmacy Benefit Manager Transparency Act of 2025, requires pharmacy benefit managers (PBMs) - the middlemen managing drug coverage for health plans - to disclose financial details and stop unfair practices. It prohibits PBMs from keeping price differences between what they charge health plans and pay pharmacies, arbitrarily clawing back payments, or inflating fees to offset government-mandated changes. PBMs must annually report to the FTC and HHS on rebate sharing, fee structures, formulary changes, and reimbursement differences, including whether drug tier shifts were influenced by manufacturers. This directly affects PBMs, pharmacies, health plans, and patients by increasing transparency in drug pricing and reimbursement.
This bill requires Medicaid programs to cover specific treatments for individuals with breast or cervical cancer. It adds a new provision to Medicaid rules that explicitly includes these patients in mandatory coverage, ensuring states must provide necessary care. The bill also mandates that Medicaid cover breast reconstruction surgery following a medically necessary mastectomy. These changes directly affect Medicaid beneficiaries diagnosed with breast or cervical cancer who need these specific treatments. The policy update removes gaps in existing coverage for these critical cancer care services.